Cost and co-morbidities associated with hypoglycemic inpatients in Belgium

References

• International Diabetes Federation. IDF Atlas, 6th edn. 2013. www.idf.org/diabetesatlas. Accessed December 2014
   Google Scholar
• National Center for Chronic Disease Prevention and Health Promotion (CDC). Diabetes: successes and opportunities for population-based prevention and control. Belgium: CDC, 2011. http://www.cdc.gov/chronicdisease/resources/publications/aag/pdf/2011/diabetes-aag-2011-508.pdf. Accessed August 2015
   Google Scholar
• Global Status Report on noncommunicable diseases 2010. Geneva: World Health Organization, 2010
   Google Scholar
• Rijksinstituut voor ziekte- en invaliditeitsverzekering. Farmaceutische kengetallen, farmaceutische verstrekkingen, ambulante praktijk. Belgium, 2013. 16th edn. 2014.
   Google Scholar
• INAMI. Le diabète en Belgique: état des lieux. Belgium, 2008. http://www.inami.fgov.be/information/fr/studies/study37/pdf/study37.pdf. Accessed December 2014
   Google Scholar
• Roglic G, Unwin N. Mortality attributable to diabetes: estimates for the year 2010. Diabetes Res Clin Pract 2010;87:15-19
   PubMed Web of Science ®Google Scholar
• Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2015;58:429-42
   PubMed Web of Science ®Google Scholar
• Hemmingsen B, Lund SS, Gluud C, et al. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Cochrane Database Syst Rev 2013;11:CD008143
   PubMed Web of Science ®Google Scholar
• Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006;55:3151-59
   PubMed Web of Science ®Google Scholar
• Cryer P. The barrier of hypoglycemia in diabetes. Diabetes 2008;57:3169-75
   PubMed Web of Science ®Google Scholar
• Rombopoulos G, Hatzikou M, Latsou D, et al. The prevalence of hypoglycemia and its impact on the quality of life (QoL) of type 2 diabetes mellitus patients (The HYPO Study). Hormones 2013;12:550-8
   PubMedGoogle Scholar
• Johnston SS, Conner C, Aagren M, et al. Association between hypoglycaemic events and fall-related fractures in Medicare-covered patients with type 2 diabetes. Diabetes Obes Metab 2012;14:634-43
   PubMed Web of Science ®Google Scholar
• Marchesini G, Veronese G, Forlani G, et al. The management of severe hypoglycaemia by the emergency system: the HYPOTHESIS study. Nutr Metab Cardiovasc Dis 2014;24:1181-8
   PubMed Web of Science ®Google Scholar
• Shao W, Ahmad R, Khutoryansky N, et al. Evidence supporting an association between hypoglycemic events and depression. Curr Med Res Opin 2013;29:1609-15
   PubMed Web of Science ®Google Scholar
• Whitmer RA, Karter AJ, Yaffe K, et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009;301:1565-72
   PubMed Web of Science ®Google Scholar
• Unger J. Uncovering undetected hypoglycemic events. Diabetes Metab Syndr Obes Targ Ther 2012;5:57-74
   PubMedGoogle Scholar
• McCoy RR, Van Houten HK, Ziegenfuss JY, et al. Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care 2012;35:1897-901
   PubMed Web of Science ®Google Scholar
• Nirantharakumar K, Marshall T, Kennedy A, et al. Hypoglycaemia is associated with increased length of stay and mortality in people with diabetes who are hospitalized. Diabet Med 2012;29:e445-8
   PubMed Web of Science ®Google Scholar
• Campbell K. Hospital strategies for insulin therapy with rapid-acting insulin analogs. Hosp Pharm 2011;46:580-90
   Google Scholar
• Budnitz D, Lovegrove M, Shehab N, et al. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011;365:2002-12
   PubMed Web of Science ®Google Scholar
• Chevalier P, Lamotte M, Joseph A, et al. In-hospital costs associated with chronic constipation in Belgium: a retrospective database study. Neurogastroenterol Motil 2014;26:368-76
   PubMed Web of Science ®Google Scholar
• Body JJ, Chevalier P, Gunther O, et al. The economic burden associated with skeletal-related events in patients with bone metastases secondary to solid tumors in Belgium. J Med Econ 2013;16:1-8
   PubMedGoogle Scholar
• Nevens F, Colle I, Michielsen P, et al. Treatment of chemotherapy-induced anemia with erythropoiesis-stimulating agents in five European Countries. J Med Econ 2012;15:409-18
   PubMedGoogle Scholar
• Financial feedback per pathology. Technical cell the Belgian Federal Ministery of Health. SPF Santé publique, Sécurité de la Chaîne alimentaire et Environnement. https://tct.fgov.be/webetct/etct-web/anonymous?lang=fr
   Google Scholar
• Turchin A, Matheny M, Shubina M, et al. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care 2011;32:1153-7
   Web of Science ®Google Scholar
• Soedamah-Muthu SS, Fuller JH, Mulnier HE, et al. High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database. Diabetes Care 2006;29:798-804
   PubMed Web of Science ®Google Scholar
• Laing SP, Swerdlow AJ, Slater SD, et al. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 2003;46:760-5
   PubMed Web of Science ®Google Scholar
• Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 1979;2:120-6
   PubMedGoogle Scholar
• Zhang P-Y. Cardiovascular diseases in diabetes. Eur Rev Med Pharmacol Sci 2014;18:2205-14
   PubMed Web of Science ®Google Scholar
• Wright RJ, Frier BM. Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev 2008;24:353-63
   PubMed Web of Science ®Google Scholar
• Snell-Bergeon J, Wadwa P. Hypoglycemia, diabetes and cardiovascular disease. Diabetes Techn Therapeut 2012;14(1 Suppl):51-8
   Google Scholar
• Action to Control Cardiovascular Risk in Diabetes Study Group (ACCORD). Effects of Intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-59
   PubMed Web of Science ®Google Scholar
• ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation) Collaborative Group, Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-72
   PubMed Web of Science ®Google Scholar
• Hsu P, Sung S, Cheng H, et al. Association of Clinical symptomatic hypoglycemia with cardiovascular events and total mortality in Type 2 diabetes. Diabetes Care 2013;36:894-900
   PubMed Web of Science ®Google Scholar
• Gore O, McGuire D. The 10-year post-trial follow-up of the United Kingdom Prospective Diabetes Study (UKPDS): cardiovascular observations in context. Diabetes Vasc Dis Resh 2009;6:53
   PubMed Web of Science ®Google Scholar
• Garg R, Hurwitz S, Turchin A, et al. Hypoglycemia, with or without insulin therapy, is associated with increased mortality among hospitalized patients. Diabetes Care 2013;36:1107-10
   PubMed Web of Science ®Google Scholar
• Lamotte M, Chevalier P, Vandebrouck T. The burden of hospitalizations due to hypoglycemia in Belgium. American Diabetes Association (ADA) 73rd Scientific Sessions, 2013, June 21-25, Chicago, IL, USA
   Google Scholar
• Geller AI, Shehab N, Lovegrove MC, et al. National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations. JAMA Intern Med 2014;174:678-86
   PubMed Web of Science ®Google Scholar
• Lacherade JC, Jacqueminet S, Preiser JC. An overview of hypoglycemia in the critically ill. J Diabetes Sci Technol 2009;3:1242-9
   PubMedGoogle Scholar